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Abstract
Background: Although blood transfusion is one of  the known therapeutic interventions that cuts across a number of  clinical 
disciplines. It is necessary to test all intending blood donors for HIV infection before donation. The aim of  this study was to 
determine the prevalence of  HIV among blood donors at Dessie Blood Bank, Northeast Ethiopia.
Methods: A retrospective study was conducted in Dessie Blood Bank through the year 2008- 2012. Sera from blood donors 
were tested for the detection of  Anti HIV by using 4th generation ELISA. Data were abstracted from records and analyzed using 
Microsoft Excel sheet. 
Results: From the total of  9384 screened blood samples collected, the prevalence of  HIV in blood donors in the blood bank 
was 5.1% in the five consecutive years but the trend of  HIV infection has decreased from 2008(5.2%) to 2012 (2.3%). The age 
groups 15-24 and 35-44 were the highest prevalence and the age group 45-54 was the lowest prevalence of  HIV infection. The 
prevalence of  HIV among female (7.9%) was higher than in male donors (4.4%). The trend of  HIV infection was decreasing for 
both male and female blood donors.
Conclusion: The prevalence of  HIV infections among blood donors is still high in this study setting, and needs constant mon-
itoring to evaluate prevention and control strategies to reduce the burden of  transfusion-transmissible HIV infections.
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Although blood transfusion is one of  the known thera-
peutic interventions that cut across a number of  clinical 
disciplines, the practice is not without risks. HIV has con-
tinued to create a great challenge to transfusion medicine, 
especially in Africa about 10-15 % of  HIV transmission 
had been correlated with blood transfusions.1 Since the 
detection that HIV is transmitted through blood trans-
fusion it became necessary to test all intending blood 
donors for HIV infection before they are transfused to 
ensure the safety of  all blood and blood products to the 
recipients.2
Sub-Saharan Africa has the most serious HIV epidemic 
in the world. In 2012, about 25 million people were living 
with HIV accounting for nearly 70% of  the global total. 
In the same year, there were an estimated 1.6 million new 
HIV infections and 1.2 million AIDS-related deaths.3
HIV prevalence varies significantly between regions in 
sub-Saharan Africa as well as individual countries. HIV 
prevalence in East Africa is generally moderate to high, 
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and next to Southern Africa. However, general preva-
lence has been in decline for the past two decades.3
In 2013, there were an estimated 793,700 people living 
with HIV. HIV adult prevalence is anticipated to be 1.5% 
in 2011, the year in which the last Ethiopian Demograph-
ic Health Survey (DHS) was conducted. However preva-
lence varies according to age, sex, gender and geograph-
ical location.4
The overall seroprevalence of  HIV was 3.8% in a study 
conducted on blood donors at Gondar university blood 
bank unit5 and the peak ages for AIDS cases were 25 to 
29 for both sexes. The age range at which people become 
infected was 15 to 24 years for females and 25 to 34 years 
for males.6 Among blood donors in Addis Ababa the 
prevalence for women was 6.9% in 1999, higher than that 
of  men.7
On the other hand, significantly declining fashion of  
HIV seroprevalence were observed in the studies done 
in blood banks of  Jimma University Specialized Hos-
pital and Gonder University hospital7,8 and NorthWest 
Ethiopia.9 The Federal Ministry of  Health reported the 
National HIV prevalence as 3.5% and 5% among blood 
donors in 2005 where the prevalence for those blood do-
nors in the age group 15-19 years was 2.9% but the high-
est prevalence occurred among donors in the age group 
of  30-39 years.10
In Nigeria, the prevalence of  HIV positive donors among 
the screened volunteers who satisfied the criteria for blood 
donation was 0.87%.11 Whereas HIV incidences of  22% 
among blood donors in Kampala Uganda in East Africa 
which is significantly higher than the Nigerian studies.12
A study in India, on a rural population in 2003 reported 
that, the prevalence of  HIV among blood donors to be 
1.56%.13 The overall seroprevalence of  HIV among the 
total blood donors in nation wide and in Central Blood 
Transfusion Service (CBTS), Kathmandu, Nepal through 
the six years of  review (from 2001-2007) was 0.33% and 
0.4% respectively.14
Moreover, there is limited epidemiological data on trans-
fusion-transmissible infections (TTI) among blood do-
nors in Ethiopia. The magnitude of  HIV among blood 
donors has shown variation across different settings in 
Ethiopia that attribute to difference in societal associated 
risk factors and screening methods used.15-19 The safety 
of  blood for transfusion is a major challenge of  Ethiopia, 
and is not well addressed. As a result, use of  unsafe blood 
products puts the patient at risk of  acquiring many TTIs. 
Such patients can become potential sources of  infection 
to the community that increase the disease burden, and 
can pose additional financial burden for diagnosis and 
treatment of  these diseases.20,21 To ensure the safety and 
adequacy of  the national blood supply in Ethiopia, mo-
bilization and recruitment of  low-risk, non-remunerated 
blood donors and testing of  donated blood for TTIs us-
ing sensitive and specific testing methods are essential.22 
Therefore, evaluating the epidemiology of  TTIs can be 
used as indicator to assess the safety blood supply and 
helps to develop strategies aimed at reducing the disease 
burden in the communities which will ensure accessibility 
of  safe blood supply to transfusion centers. Therefore, 
the aim of  this study was to provide information about 
the trend of  HIV seropositivity among the blood donors 
at Dessie blood bank over the study period and this would 
allow comparison of  the seropositivity over the course of  
time. The finding could also be used to update interven-




A retrospective study was conducted at Dessie District 
Blood Bank during July to September 2013 by reviewing 
the log book’s 2008-2012 data. This was a retrospective 
study conducted in Dessie Blood Bank Center. The study 
population was all blood donors who donated blood at 
Dessie Blood Bank from 2008-2012.The participants 
were those who weighed not less than 50 kg and were 
age of  greater than or equal to 18 years old. A total of  
9384 blood donors’ records were reviewed and included 
in the study. Serum samples were tested for HIV using 
fourth generation Enzyme Linked Immunosorbent Assay 
(ELISA) (HIV1/2: Vironostika HIV Uni-Form II AG/
Ab, Bio-Merieux, Boxtel, Netherlands). All the tests were 
done following the manufacturer’s instructions.
Data on socio-demographic variables, laboratory test 
results were collected from registration book of  Dessie 
District Blood Bank using data extraction format. Data 
were cross-checked for completeness. The data was 
cleaned, edited and entered into computer and analyzed 
using Microsoft Excel sheet and the results were present-
ed in tables and paragraph.
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Ethical approval
Ethical clearance was obtained from Wollo University 
Ethical Review Committee and verbal consent was ob-
tained from Blood Bank administration before the com-
mencement of  data collection. Confidentiality of  the in-
formation was ensured as codes instead of  the names of  
the subjects were registered on the data collection format.
Results
During the 5-year period, 9,384 individuals donated blood 
and screened for HIV infections. From the total donors, 
7514 (80.1%) and 1870 (19.9%) were male and female 
donors respectively. More men participated in the survey 
than women, with a male-to-female gender ratio of  4.01.
The finding of  this study showed that there were 476 
HIV positive blood donors. Therefore, the overall preva-
lence of  HIV infection in blood donors was found to be 
5.1% in the five consecutive years (Figure 1 and Table 1). 
 
 
Fig.1: Trend of HIV prevalence among blood donors at Dessie Blood 
from 2008-2012 
Table 1: Trend of HIV prevalence among blood donors at 
Dessie Blood Bank from 2008-2012 
 
Year No of Units screened 
HIV positive 
N % 
2008 1432 75 5.2 
2009 1538 112 7.3 
2010 1720 136 7.9 
2011 1924 89 4.6 
2012 2770 64              2.3 
Total 9384 476 5.1 
 
The trend of  HIV infection has decreased from 2008 to 
2012. Considering age, the age groups 15-24 and 25-34 
had the highest contribution and the age group 55-65 the 
lowest contribution of  HIV infection (Table 2 and 3).
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Table 2: Infection with HIV among blood donors at Dessie Blood Bank by 







group        2008 2009 2010 2011 2012      N % 
15-24 33 48 66 25 26    198  41.6 
25-34 19 47 46 48 30 190 40 
35-44 14 13 14 15 8 64 13.4 
45-54 7 2 9 1 - 19   4 
55-65 2 2 1 - - 5 1 
Total 75 112 136 89 64 476  100 
  
 




Age Total donors HIV positive Prevalence 
15-24 2938 198 6.75 
25-34 4355 190 4.36 
35-44 1023 64 6.25 
45-54 865 19 2.20 
55-65 206 5 2.43 
Total 9384 476 5.1 
African Health Sciences Vol 17 Issue 3, September, 2017  715
As indicated in table 4 the prevalence of  HIV among fe-
male blood donors (7.9%) was higher than among male 
donors (4.4%). The trend of  HIV infection was decreas-
ing for both male and female blood donors.
Table 4: Distribution of HIV positive blood donors by gender at dessie 















2008 1432 1194 238 54 (4.5) 21(8.8) 
2009 1538 1201 337 76(6.3) 36(10.7) 
2010 1720 1373 347 98(7.1) 38 (11.0) 
2011 1924 1502 422 61(4.1) 28(6.6) 
2012 2770 2244 526 40 (1.8) 24(4.6) 
Total 9384 7514 1870 329(4.4) 147 (7.9) 
 
Discussion
Blood transfusion is considered as a potential risk factor 
for transmission of  viruses which are considered to be 
life-threatening and have a global public health impor-
tance such as HIV.  In this study, the overall prevalence 
of  HIV infection was 476 (5.1%) but showed a decreas-
ing trend from 2008 to 2012.  A decreasing trend in HIV 
seroprevalence among blood donors was reported from 
Kathmandu, Nepal14  and West African country, Mali.15
The prevalence of  HIV is lower when compared with 
previous studies done in Ethiopia: Bahir dar, NorthWest 
Ethiopia9 and Jimma, Ethiopia8. It is also lower than stud-
ies done in African countries.5,11,16-19,23-25 Our study report-
ed higher prevalence of  HIV infection compared to pre-
vious studies done in Hawassa, Ethiopia (1.6%)15, Jijiga, 
Ethiopia (0.1%)16, Iran (0.004%)26, Mangalore (0.1%)27, 
Egypt (0%)28 and Jordan (0%)29. Such differences in sero-
prevalence rate might be due to some differences in risk 
behaviors, geographical variation, educational programs, 
preventive measures, public awareness,  condition of  ep-
idemic, donor selection criteria and selection procedure, 
sensitivity and specificity of  screening technologies em-
ployed in blood transfusion centers of  those countries 
by performance characteristics of  test kits as well as diag-
nostic algorithms used in each study.
Sex specific prevalence of  HIV infection was 4.4% for 
males and 7.9% for females. The difference between the 
two sexes was consistent with other studies that showed 
a higher prevalence among females.8,30,31, yet the age spe-
cific prevalence was highest among the age group 15-24 
years followed by those who were 25-34 years. The higher 
rate of  seroprevalence in these age groups might be at-
tributed to their being more sexually active.
Conclusion
The prevalence of  HIV infections among blood donors 
is still high in this study setting, and needs constant mon-
itoring to evaluate prevention and control strategies. To 
reduce the possible risk of  infections, provision of  strict 
criterion in recruitment of  blood donors by promoting 
the culture of  voluntary blood donations, screening of  
blood and blood products for these pathogens using sen-
sitive laboratory test kits are imperious. Creating com-
munity awareness about the mode of  transmission and 
prevention of  HIV infection should be strengthened by 
giving health education. Moreover, conducting further 
community-based studies to identify societal risk factors 
exposing communities for blood-borne infections and 
developing population-specific interventions to interrupt 
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